Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing.

To assess the clinical utility of targeted Next-Generation Sequencing (NGS) for the diagnosis of Inherited Retinal Dystrophies (IRDs), a total of 109 subjects were enrolled in the study, including 88 IRD affected probands and 21 healthy relatives. Clinical diagnoses included Retinitis Pigmentosa (RP...

Descripción completa

Detalles Bibliográficos
Publicado en:BioMed Research International Vol. 2016; pp. 1 - 15
Autores principales: Bernardis, Isabella, Chiesi, Laura, Tenedini, Elena, Artuso, Lucia, Percesepe, Antonio, Artusi, Valentina, Simone, Maria Luisa, Manfredini, Rossella, Camparini, Monica, Rinaldi, Chiara, Ciardella, Antonio, Graziano, Claudio, Balducci, Nicole, Tranchina, Antonia, Cavallini, Gian Maria, Pietrangelo, Antonello, Marigo, Valeria, Tagliafico, Enrico
Formato: research tables/charts Journal Article
Publicado: Wiley-Blackwell 12/29/2016
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=120459233&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 120459233
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        23146133
        FT2T
      jtl: BioMed Research International
      issn: 23146133
      maglogo: N
    pubinfo:
      dt: 12/29/2016
      vid: 2016
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        120459233
        120459233
        120459233
        10.1155/2016/6341870
        120459233
      ppf: 1
      ppct: 14
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing.
      aug:
        au:
          Bernardis, Isabella
          Chiesi, Laura
          Tenedini, Elena
          Artuso, Lucia
          Percesepe, Antonio
          Artusi, Valentina
          Simone, Maria Luisa
          Manfredini, Rossella
          Camparini, Monica
          Rinaldi, Chiara
          Ciardella, Antonio
          Graziano, Claudio
          Balducci, Nicole
          Tranchina, Antonia
          Cavallini, Gian Maria
          Pietrangelo, Antonello
          Marigo, Valeria
          Tagliafico, Enrico
        affil: Center for Genome Research, University of Modena and Reggio Emilia, Modena, Italy
      sug:
        subj:
          Retinal Diseases Familial and Genetic
          Sequence Analysis Methods
          Genetic Screening Methods
          Retinal Diseases Diagnosis
          Human
          Italy
          Retinitis Pigmentosa Diagnosis
          Eye Diseases, Hereditary Diagnosis
          Macular Degeneration Diagnosis
          Usher's Syndrome Diagnosis
          Ophthalmology
          Genetic Counseling
          Mutation
          Descriptive Statistics
          Cost Benefit Analysis
          Pathology, Molecular
          Phenotype
          Male
          Female
          Adolescence
          Adult
          Middle Age
          Child, Preschool
          Child
          Aged
          Aged, 80 and Over
          Academic Medical Centers
          Data Analysis Software
          Funding Source
          Adolescent: 13-18 years
          Adult: 19-44 years
          Middle Aged: 45-64 years
          Child, Preschool: 2-5 years
          Child: 6-12 years
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: To assess the clinical utility of targeted Next-Generation Sequencing (NGS) for the diagnosis of Inherited Retinal Dystrophies (IRDs), a total of 109 subjects were enrolled in the study, including 88 IRD affected probands and 21 healthy relatives. Clinical diagnoses included Retinitis Pigmentosa (RP), Leber Congenital Amaurosis (LCA), Stargardt Disease (STGD), Best Macular Dystrophy (BMD), Usher Syndrome (USH), and other IRDs with undefined clinical diagnosis. Participants underwent a complete ophthalmologic examination followed by genetic counseling. A custom AmpliSeq™ panel of 72 IRD-related genes was designed for the analysis and tested using Ion semiconductor Next-Generation Sequencing (NGS). Potential disease-causing mutations were identified in 59.1% of probands, comprising mutations in 16 genes. The highest diagnostic yields were achieved for BMD, LCA, USH, and STGD patients, whereas RP confirmed its high genetic heterogeneity. Causative mutations were identified in 17.6% of probands with undefined diagnosis. Revision of the initial diagnosis was performed for 9.6% of genetically diagnosed patients. This study demonstrates that NGS represents a comprehensive cost-effective approach for IRDs molecular diagnosis. The identification of the genetic alterations underlying the phenotype enabled the clinicians to achieve a more accurate diagnosis. The results emphasize the importance of molecular diagnosis coupled with clinic information to unravel the extensive phenotypic heterogeneity of these diseases.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N